At AAIC 2025, UKDTN hosted a roundtable on improving diversity in dementia trials, generating actionable insights now being developed into a white paper, with further international engagement planned at CTAD 2025.  

A joint UKDTN and Alzheimer’s Society survey of 1,200 patients and carers revealed strong interest in research but low participation, with findings to inform future UKDTN priorities and improve participant experience.    

UKDTN has awarded its first five fellowships across the UK, with outstanding applications highlighting strong potential for future clinical trial leaders.